- Exchange: OTC BB
- Sector: Consumer, Non-cyclical
- Industry: Healthcare-Products
- Sub-Industry: Medical Imaging Systems
FluoroPharma Medical Inc
+ Add to WatchlistFPMI:US
0.7700 USD 0.0300 3.75%As of 20:10:00 ET on 05/17/2013.
Snapshot for FluoroPharma Medical Inc (FPMI)
| Open: | 0.7300 | Day's Range: | 0.6500 - 0.8100 | Volume: | 84,050 |
|---|---|---|---|---|---|
| Previous Close: | 0.8000 | 52wk Range: | 0.5100 - 1.1900 | 1-Yr Rtn: | +1.32% |
Key Statistics for FPMI
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(-) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (ttm) | - |
| Est. EPS | - |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 18.76 |
| Shares Outstanding (M) | 24.36 |
| 30 Day Average Volume | 31,022 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | - |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for FPMI
No data available
Company Profile & Key Executives for FPMI
FluoroPharma Medical Inc. is a molecular imaging company. The Company engages in the discovery, development and commercialization of proprietary diagnostic imaging products. FlouroPharma's initial focus is the development of positron emission tomography (PET) imaging agents for the detection and assessment of acute and chronic forms of coronary artery disease.
| Johan M Spoor "Thijs"Chairman/President/CEO | Boyan GoumnerovVP:Clinical Trials/COO |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
FPMI News
-
Industry News
No stories found
No stories found
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page